B.Riley/FBR Downgrades EyePoint Pharmaceuticals, Inc. (EYPT) to Neutral
Tweet Send to a Friend
B.Riley/FBR analyst Andrew D\'Silva downgraded EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
